Tentarix
Founded 2020 · 56 employees on LinkedIn · 1 known investors
Tentarix develops conditionally active multispecific biologics with high therapeutic index aimed at difficult-to-treat targets. Its technology is applied to complex therapeutic areas including oncology, immuno-oncology, and autoimmune disease.
Investors · 1
Frequently asked questions
- What does Tentarix do?
- Tentarix develops conditionally active multispecific biologics with high therapeutic index aimed at difficult-to-treat targets. Its technology is applied to complex therapeutic areas including oncology, immuno-oncology, and autoimmune disease.
- Who are Tentarix's investors?
- Tentarix's investors include Versant Ventures.